Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosrenol for Hyperphosphatemia in Non-Dialysis CKD Patients
NCT01110629Phase 3Completed
- Sponsor
- Bayer
- Start
- Jun 2010
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lanthanum carbonate in hyperphosphatemia, sponsored by Bayer. Started Jun 2010; status: completed.
02
Drugs
lanthanum carbonate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT01110629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01110629.